JCI Insight · 2023 · 19 citations · 40 references
Veterinary MedicineImmunologyInfectious DiseasesImmunology Of Infectious DiseasesMucosal ImmunologyVaccinologyAdaptive Immune ResponsesAntibody CharacterizationHumoral ImmunityImmune Response To VaccinationMucosal ImmunityVaccinationAntibodiesAntigen-antibody RecognitionInfectious Mucosal ImmunityMucosal AntibodiesPreexisting Antiviral ImmunitySalivary AntibodiesSalivary Neutralizing AntibodiesVaccine-induced Adaptive Immunity
Understanding mucosal antibody responses from SARS-CoV-2 infection and/or vaccination is crucial to develop strategies for longer term immunity, especially against emerging viral variants. We profiled serial paired mucosal and plasma antibodies from COVID-19 vaccinated only vaccinees (vaccinated, uninfected), COVID-19-recovered vaccinees (recovered, vaccinated), and individuals with breakthrough Delta or Omicron BA.2 infections (vaccinated, infected). Saliva from COVID-19-recovered vaccinees displayed improved antibody-neutralizing activity, Fcγ receptor (FcγR) engagement, and IgA levels compared with COVID-19-uninfected vaccinees. Furthermore, repeated mRNA vaccination boosted SARS-CoV-2-specific IgG2 and IgG4 responses in both mucosa biofluids (saliva and tears) and plasma; however, these rises only negatively correlated with FcγR engagement in plasma. IgG and FcγR engagement, but not IgA, responses to breakthrough COVID-19 variants were dampened and narrowed by increased preexisting vaccine-induced immunity against the ancestral strain. Salivary antibodies delayed initiation following breakthrough COVID-19 infection, especially Omicron BA.2, but rose rapidly thereafter. Importantly, salivary antibody FcγR engagements were enhanced following breakthrough infections. Our data highlight how preexisting immunity shapes mucosal SARS-CoV-2-specific antibody responses and has implications for long-term protection from COVID-19.
40
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman, Olfert Landt, Marco Kaiser et al. · Eurosurveillance · 2020 · 8.2K citations · Full text
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Delphine Sterlin, Alexis Mathian, Makoto Miyara et al. · Science Translational Medicine · 2020 · 1.1K citations · Full text
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Kevin W. Ng, Nikhil Faulkner, Georgina H. Cornish et al. · Science · 2020 · 985 citations · Full text
Jasper Fuk‐Woo Chan, Cyril Chik‐Yan Yip, Kelvin Kai‐Wang To et al. · Journal of Clinical Microbiology · 2020 · 936 citations · Full text